Vaccination against viral hepatitis B in patients undergoing liver transplantation for hepatitis B-unassociated causes
To study efficiency of molgramostim as an adjuvant in HBV vaccination we randomized 18 pts after OLT due to non-HBV causes. Nine pts received GM-CSF (150 mcg of sc 24 h before 1st dose of vaccine). Other 9 pts received only vaccine. Both groups of pts did not differ in sex, age, immunosuppression an...
| Autori principali: | , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2018-08-01
|
| Serie: | Трансплантология (Москва) |
| Soggetti: | |
| Accesso online: | https://www.jtransplantologiya.ru/jour/article/view/289 |